REPR November Investor Presentation – 11.13.18

This presentation contains forward-looking statements that involve risks and uncertainties, including but not limited to those related to the growth of the home infusion market, our SG&A expenditures and the potential for Nasdaq uplisting. Actual results and events may differ significantly from results and events discussed in the forward-looking statements. Factors that might cause or … Continued

Liolis Gateway September 2018 Presentation

This presentation contains forward-looking statements that involve risks and uncertainties, including but not limited to those related to the growth of the home infusion market, our SG&A expenditures and the potential for Nasdaq uplisting. Actual results and events may differ significantly from results and events discussed in the forward-looking statements. Factors that might cause or … Continued

RMS Receives FDA Clearance for 510(k)

RMS Freedom Infusion System Cleared for Both Subcutaneous and Intravenous Indications CHESTER, NY / September 05, 2017 / Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) announces the FDA issued a new 510(k) clearance for the RMS “Integrated Catch-Up Freedom Syringe Driver Infusion System” effective August 31, 2017.  The Freedom System is the … Continued